National Research Investment Act of 1998 - States purposes of this Act, including to double the annual authorized amount of Federal funding for basic scientific, medical, and pre-competitive engineering research over the ten-year period following enactment of this Act.
Authorizes appropriations for covered research and development for FY 1999 through 2008 to be used by the National Institutes of Health of the Department of Health and Human Services. Sets forth limitations on the use of such funds.
[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3660 Introduced in House (IH)]
105th CONGRESS
2d Session
H. R. 3660
To invest in the future of the United States by doubling the amount
authorized for basic scientific, medical, and pre-competitive
engineering research.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 1, 1998
Mr. Kennedy of Massachusetts (for himself, Mrs. Tauscher, Mr. Neal of
Massachusetts, Mr. Filner, Mr. Kucinich, Mr. McGovern, Mr. Romero-
Barcelo, Mr. Gejdenson, Ms. Rivers, Ms. Woolsey, Mr. Frost, Mrs.
McCarthy of New York, Mr. Moran of Virginia, Mr. Snyder, Mr.
Faleomavaega, Mr. LaTourette, Mr. Houghton, and Mr. Davis of Virginia)
introduced the following bill; which was referred to the Committee on
Science, and in addition to the Committees on Commerce, and
Agriculture, for a period to be subsequently determined by the Speaker,
in each case for consideration of such provisions as fall within the
jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To invest in the future of the United States by doubling the amount
authorized for basic scientific, medical, and pre-competitive
engineering research.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``National Research Investment Act of
1998''.
SEC. 2. FINDINGS; PURPOSES.
(a) Findings.--Congress finds that--
(1) for fiscal year 1965, 5.7 percent of the Federal budget
was expended for nondefense research and development
activities;
(2) for fiscal year 1997, the percentage of the Federal
budget allocated for nondefense research and development
activities is 1.9 percent, which is 67 percent less than the
percentage in fiscal year 1965;
(3) for the first time in 25 years during the period
beginning with fiscal year 1992 and ending with fiscal year
1995, the amount of funds expended by the Federal Government on
research (expressed in real dollars) declined each year;
(4) during the period beginning with fiscal year 1970, and
ending with fiscal year 1995, the United States had not, during
any fiscal year, expended an amount for nondefense research and
development activities, that, expressed as a percentage of the
Gross Domestic Product, was greater than or equal to the
percentage expended by Japan or Germany for that fiscal year;
and
(5) an increased level of investment in basic scientific,
medical, and pre-competitive engineering research by the
Federal Government is essential to maintaining the position of
the United States as the technological leader of the world.
(b) Purposes.--The purposes of this Act are as follows:
(1) To double the annual authorized amount of Federal
funding for basic scientific, medical, and pre-competitive
engineering research over the 10-year period following the date
of enactment of this Act, so that the amount of Federal funding
for fiscal year 2008 is equal to $68,000,000,000.
(2) To restore the high priority that science and
technology had previously been afforded in the Federal budget.
(3) To invest in the future of the United States and the
people of the United States by expanding the research
activities referred to in paragraph (1).
(4) To enhance the quality of life for all the people of
the United States.
(5) To guarantee the leadership of the United States in
science, medicine, and technology.
SEC. 3. AUTHORIZATIONS OF APPROPRIATIONS.
(a) Funds for Covered Research and Development Defined.--For
purposes of this section, the term ``funds for covered research and
development'' means--
(1) any funds made available by appropriations for--
(A) the National Institutes of Health of the
Department of Health and Human Services;
(B) the National Science Foundation; and
(C) the National Institute for Standards and
Technology of the Department of Commerce;
(2) any funds made available by appropriations for use for
research and development activities (as that term is used in
the most recent applicable appropriations Act with respect to a
Federal Agency) for basic scientific, medical, or pre-
competitive engineering research--
(A) by the National Aeronautics and Space
Administration;
(B) by the National Oceanic and Atmospheric
Administration of the Department of Commerce;
(C) by the Centers for Disease Control and
Prevention of the Department of Health and Human
Services;
(D) by the Department of Energy (to the extent that
the activities are not defense-related activities);
(E) by the Department of Agriculture;
(F) by the Department of Veterans Affairs;
(G) by the Smithsonian Institution;
(H) by the Department of Education;
(I) by the Department of the Interior; and
(J) by the Department of Transportation; and
(3) any funds made available by appropriations to the
Environmental Protection Agency for science and technology
activities for basic scientific, medical, or pre-competitive
engineering research.
(b) Authorization of Appropriations.--
(1) In general.--Subject to the limitations under paragraph
(2), there are authorized to be appropriated as funds for
covered research and development--
(A) for fiscal year 1999, $37,400,000,000, of which
$14,960,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(B) for fiscal year 2000, $40,800,000,000, of which
$16,320,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(C) for fiscal year 2001, $44,200,000,000, of which
$17,680,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(D) for fiscal year 2002, $47,600,000,000, of which
$19,040,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(E) for fiscal year 2003, $51,000,000,000, of which
$20,400,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(F) for fiscal year 2004, $54,400,000,000, of which
$21,760,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(G) for fiscal year 2005, $57,800,000,000, of which
$23,120,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(H) for fiscal year 2006, $61,200,000,000, of which
$24,480,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services;
(I) for fiscal year 2007, $64,600,000,000, of which
$25,840,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services; and
(J) for fiscal year 2008, $68,000,000,000, of which
$27,200,000,000 shall be used by the National
Institutes of Health of the Department of Health and
Human Services.
(2) Limitations.--
(A) Development of public information.--In using
funds made available under this section, the
appropriate officials shall take such action as may be
necessary to ensure that priority is given to basic
scientific, medical, and pre-competitive engineering
research that has the purpose of developing scientific
information to be available to the general public.
(B) Use of funds.--No funds made available pursuant
to the authorization under this subsection may be used
for commercial purposes, except that such funds may
only be used for pre-competitive research and
development for technology.
(C) Peer review.--In allocating funds made
available under this section, the appropriate officials
shall take such action as may be necessary to ensure
that a peer review system is used.
SEC. 4. COMPLIANCE WITH DISCRETIONARY CAPS.
Notwithstanding any other provision of law, no funds may be made
available under this Act in a manner that does not conform with the
discretionary spending caps provided in the most recently adopted
concurrent resolution on the budget.
<all>
Introduced in House
Introduced in House
Referred to House Science
Referred to the Committee on Science, and in addition to the Committees on Commerce, and Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to House Commerce
Referred to House Agriculture
Referred to the Subcommittee on Forestry, Resource Conservation and Research.
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Referred to the Subcommittee on Energy and Power, for a period to be subsequently determined by the Chairman.
Referred to the Subcommittee on Finance and Hazardous Materials, for a period to be subsequently determined by the Chairman.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line